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Abstract 1 
 2 
Chronic stress is a major cause of anxiety disorders that can be reliably modeled 3 
pre-clinically, providing insight into alternative therapeutic targets for this mental 4 
health illness. Neuropeptides have been targeted in the past to no avail possibly due 5 
to our lack of understanding of their role in pathological models. In this study we 6 
use a rat model of chronic stress-induced anxiety-like behaviours and hypothesized 7 
that neuropeptidergic modulation of synaptic transmission would be altered in the 8 
Bed Nucleus of the Stria Terminalis (BNST), a brain region suspected to contribute 9 
to anxiety disorders. We use brain slice neurophysiology and behavioural 10 
pharmacology to compare the role of locally released endogenous neuropeptides on 11 
synaptic transmission in the oval (ov) BNST of non-stressed (NS) or chronic 12 
unpredictably stressed (CUS) rats. We found that in NS rats, post-synaptic 13 
depolarization induced the release of vesicular neurotensin (NT) and corticotropin 14 
releasing factor (CRF) that co-acted to increase ovBNST inhibitory synaptic 15 
transmission in 59% of recorded neurons. CUS bolstered this potentiation (100% of 16 
recorded neurons) through an enhanced contribution of NT over CRF. In contrast, 17 
locally-released opioid neuropeptides decreased ovBNST excitatory synaptic 18 
transmission in all recorded neurons, regardless of stress. Consistent with CUS-19 
induced enhanced modulatory effects of NT, blockade of ovBNST neurotensin 20 
receptors completely abolished stress-induced anxiety-like behaviours in the 21 
elevated plus maze paradigm. The role of NT has been largely unexplored in stress 22 
and our findings highlight its potential contribution to an important behavioural 23 
consequence of chronic stress, that is, exaggerated avoidance of open space in rats. 24 
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Introduction 1 
While the stress response is integral for survival, prolonged exposure to 2 
stressors can have damaging consequences. Repeated exposure to aversive 3 
stressors predicts and contributes to mental illnesses such as generalized anxiety 4 
disorders (GAD), major depressive disorder (MDD), or post-traumatic stress 5 
disorder (PTSD) (Deppermann et al, 2014; Gosselin and Laberge, 2003; Hammen et 6 
al, 2009).  However, the biochemical imbalances caused by repeated stress in the 7 
brain remain elusive and animal models of chronic stress are essential to elucidate 8 
these mechanisms (Conrad et al, 2011).  9 
Repeated aversive stressors result in increased volume and dendritic 10 
branching as well as long-term alterations of excitatory synaptic transmission in the 11 
bed nucleus of the stria terminalis (BNST) (Conrad et al, 2011; Dabrowska et al, 12 
2013; Glangetas et al, 2013; Hubert and Muly, 2014; McElligott et al, 2010; Pego et 13 
al, 2008; Vyas et al, 2003). Surprisingly, the effects of chronic stress on local γ-14 
aminobutyric acid (GABA) transmission, imperative for fine-tuning neuronal output, 15 
have been largely unexplored in the BNST. Neuropeptides are potent modulators of 16 
GABA transmission in the BNST, but whether their function is altered in chronically 17 
stressed rats has never been investigated (Crowley et al, 2016; Kash and Winder, 18 
2006; Krawczyk et al, 2013). Neuropeptides in the BNST may be affected by chronic 19 
stress due to their involvement in the modulation of stress- or aversion-related 20 
phenomena (Lezak et al, 2014; Walker et al, 2009). 21 
 Specifically, the oval nucleus of the BNST (ovBNST) contains high 22 
concentrations of many different neuropeptides and activation of this specific 23 
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nucleus increases anxiety-like behaviours suggesting it may be sensitive to chronic 1 
stress (Kim et al, 2013). Therefore, we hypothesized that chronic stress would 2 
change neuropeptide modulation of synaptic transmission in the ovBNST. We used 3 
the chronic unpredictable stress (CUS) paradigm to test this hypothesis, a preclinical 4 
model that mimics every day stressors and invariably increases anxiety-like 5 
behaviours in rats (Cerqueira et al, 2007). Interestingly, the neuromodulatory 6 
effects of neurotensin (NT), but not of corticotropin releasing factor (CRF), became 7 
sensitized after one-month exposure to CUS. Accordingly, in vivo pharmacological 8 
blockade of ovBNST NT receptors had an anxiolytic effect in CUS rats. The 9 
neuropeptide NT is therefore a significant contributor to ovBNST promotion of 10 
anxiety-like behaviour in chronically stressed animals. 11 
 12 
Methods and Materials 13 
Rats 14 
One hundred and thirty-three adult male rats (Charles River Laboratories, 15 
Canada/Spain) weighing 350-450g were included in the electrophysiology 16 
experiments (Wistar and Long Evans rats, n=63) and behavioural experiments 17 
(Wistar rats, n=70). The rats were maintained on an artificial 12h light/dark cycle 18 
(8:00 A.M. lights on/8:00 P.M. lights off) or 12h dark/light cycle (8:00 A.M. lights 19 
off/8:00 P.M. lights on). 20 
The rats acclimatized for a minimum of 1 week upon arrival to the facility. 21 
Rat chow and water were provided ad libitum in the home cages. Sixty-three rats 22 
were used for electrophysiology (Canada), 33 rats performed the elevated plus 23 
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maze (Portugal), and 37 rats performed the elevated plus maze and the forced swim 1 
test (Canada). All experiments were conducted in accordance with the guidelines 2 
from the Canadian Council on Animal Care in Science and approved by the Queen's 3 
University Animal Care Committee and with Portugal local regulations (European 4 
Union Directive 86/609/EEC). 5 
Slices preparation and electrophysiology 6 
Rats were anesthetized with isoflurane (5% at 5 L/min) and their brains 7 
removed into ice-cold artificial cerebral spinal fluid (aCSF) containing (in mM): 126 8 
NaCl, 2.5 KCl, 1.2 MgCl2, 6 CaCl2, 1.2 NaH2PO4, 25 NaHCO3, and 12.5 D-glucose 9 
equilibrated with 95% O2/5% CO2. Brains were cut in 2°C aCSF into coronal slices 10 
(250 μm) with a vibrating blade microtome (VT-1000; Leica). We used the slice 11 
corresponding to -0.26mm from bregma. Slices were incubated at 34°C for 60 12 
minutes and transferred to a chamber perfused (3 ml/min) with aCSF at 34°C. 13 
Remaining slices were kept in aCSF at room temperature until further use. Whole-14 
cell voltage-clamp recordings were made using glass microelectrodes (3-5 MΩ) 15 
filled with (in mM): 70 K+-gluconate, 80 KCl, 1 EGTA, 5 HEPES, 2 MgATP, 0.3 GTP, 16 
and 1 P-creatine. We recorded lateral from an imaginary line drawn vertically 17 
across the lateral ventricle and medial to the internal capsule. In the dorso-ventral 18 
plan, we only recorded dorsally to an imaginary horizontal line drawn half-way 19 
between the ventral tip of the lateral ventricle and the top of the anterior 20 
commissure as illustrated in our previous publications (Krawczyk et al, 2011a; 21 
Krawczyk et al, 2011b). Paired electrical stimuli (10–100 μA, 0.1 ms duration, 20 22 
Hz) were applied at 0.1 Hz. Excitatory or inhibitory post-synaptic currents 23 
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(E/IPSCs) were evoked by local fiber stimulation with tungsten bipolar electrodes 1 
while neurons were voltage-clamped at −70 mV. GABAA-IPSC and AMPA-EPSC were 2 
pharmacologically isolated with 6,7-dinitroquinoxaline-2,3-dione (DNQX; 50 µM) or 3 
picrotoxin (100µM), respectively. To induce local endogenous neuropeptide release, 4 
post-synaptic neurons were repetitively depolarized in voltage clamp from -70 to 0 5 
mV (100 ms) at a frequency of 2 Hz for 5 mins (Iremonger and Bains, 2009).  6 
We defined long-lasting post-synaptic depolarization-induced changes in E 7 
or IPSCs peak amplitude as a >20% deviation from baseline, 25 mins following the 8 
end of the repetitive depolarization protocol. Recordings were made using a 9 
Multiclamp 700B amplifier and a Digidata 1440A (Molecular Devices Scientific). 10 
Data were acquired and analyzed with Axograph X running on Apple computers. 11 
Drugs 12 
Stock solutions of SR 142948 (10 mM) and naloxone (1 mM) were prepared 13 
in double-distilled water and stock solutions of DNQX (100 mM), NBI-27914 (50 14 
mM), Concanamycin A (1mM) were prepared in DMSO (100%). All drugs were 15 
further dissolved in the physiological solutions or 0.9% saline at the desired 16 
concentrations (DNQX 50μM, SR-142948 5-10 μM, NBI-27914 1 μM, Concanamycin 17 
A 5 μM, naloxone 1 μM) and the final DMSO concentration never exceeded 0.1%. 18 
Drugs were obtained from Sigma-Aldrich or R&D Systems.  19 
Chronic Unpredictable Stress (CUS)  20 
Rats were singly-housed and randomly assigned to non-stressed (NS) or CUS 21 
groups. Rats in the NS group were handled regularly over 4 weeks. Rats in the CUS 22 
group were exposed to 4 weeks of daily exposure to one stressor (10-60 min/day) 23 
©    2017 Macmillan Publishers Limited. All rights reserved.
  7 
at different times, as described previously (Cerqueira et al, 2007). Stressors 1 
presentation was randomized and included one of the following aversive stimuli: 2 
cold water immersion (18°C, 60 mins), home cage shaking (10 mins), restraining 3 
(60 mins), overcrowding (3-4 rats/cage, 60 mins), and exposure to hot air stream 4 
(15 mins).  5 
Surgery 6 
Rats were positioned in a stereotaxic instrument and secured by non-rupture 7 
ear bars under isoflurane (2-3%, 5L/min) or ketamine/medetomidine anaesthesia. 8 
Double guide cannulas (Plastics One) were bilaterally implanted 1 mm above the 9 
upper limit of the oval region of the dorsal BNST (−0.26 A.P., ±1.9 M.L., −6.5 D.V.). 10 
Injector cannulas (Plastics One) were placed into the guide cannulas (7.5 mm 11 
length). All stereotaxic coordinates were relative to bregma. The head attachment 12 
was secured in place via four 0.08 × 0.125 in jeweler screws and dental acrylic 13 
cement. The guide cannulas were fitted with an autoclaved 30 Ga stylet and covered 14 
with a screw-on dust cap. Following surgery, the rats recovered for one week and 15 
then were randomly assigned to six experimental groups: NS (saline, n=11); NS SR 5 16 
(SR-142948 5 μM, n=8), NS SR 10 (SR-142948 10 μM, n=6), CUS saline (saline, 17 
n=16), CUS SR 5 (SR-142948 5 μM, n=12) and CUS SR 10 (SR 142948 10 μM, n=17). 18 
Three rats (2 in the NS SR5 group and 1 in the NS SR 10 group) were euthanized 19 
before the forced swim test due to health issues. 20 
Behavioural Tests 21 
The rats were placed in the NS groups or the CUS groups receiving a 300nL 22 
injection of either saline, SR-142948 5 μM, or SR-142948 10 μM 30 mins before 23 
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testing (Binder et al, 2001). Behavioural testing was done on 3 consecutive days, 1 
starting with the elevated-plus maze (EPM) followed by the forced swim test (FST).  2 
Elevated Plus Maze (EPM) 3 
Rats were tested for 5 mins in the EPM using a black polypropylene “plus”-4 
shaped maze (Med Associates) as previously described (Pego et al, 2008). The maze 5 
consisted of two facing open arms (50.8 x 10.2 cm) and two closed arms (50.8 x10.2 6 
x 40.6 cm), 72 cm above the floor. Testing was performed under bright white light 7 
( 40 lux). The time spent in the open arms, junction area and closed arms, as well 8 
as the number of entrances and explorations in each section were recorded using a 9 
system of infrared photo beams, the crossings of which were monitored by a 10 
computer. The times spent in each of the compartments of the EPM are presented as 11 
percentage of the total duration of the trial.  12 
Forced Swim Test (FST)   13 
Rats were introduced to a cylindrical container filled with 30 cm of water 14 
(23-25°C) for 15 minutes during pre-test and 5 mins during testing. The rats’ 15 
behaviour was categorized as 1) immobile, 2) swimming and 3) climbing (included 16 
diving). We defined immobile as the absence of directed movements, climbing as 17 
vertical movement of the forepaws and swimming as horizontal movement in the 18 
swim chamber. The predominant behaviour over each 5-sec period of the 300-sec 19 
test was rated over a total score of 60 by an experimenter blind to the 20 
pharmacological treatment or the stress group. 21 
Open Field 22 
Animals were individually tested for 5 min each in an open field (OF) arena (43.2 × 23 
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43.2 cm) that had transparent acrylic walls and a white floor (model ENV-515, 1 
MedAssociates Inc, St. Albans, VT 05478). Each subject was initially placed in the 2 
center of the arena and horizontal activity and instant position were registered, 3 
using a system of two 16-beam infrared arrays connected to a computer. Total 4 
distances were used as indicators of locomotor activity. 5 
Histological Procedures  6 
Following behavioural testing, the rats were anaesthetized with 7 
pentobarbital or isoflurane. Extracted brains were submerged in fresh 8 
paraformaldehyde for 2 days and switched to 30% sucrose paraformaldehyde for 9 
cryoprotection. The brains were kept at −80°C until histology. Thirty μm coronal 10 
sections were sliced and stained with cresyl violet to assess the location of the 11 
central injections (Figure 5B,C).  12 
RNA extraction and reverse transcription 13 
Brain sections containing the dorsal BNST or the central amygdala (Figure 14 
S1) were collected from RNAlater (ThermoFisher Scientific) solution with a sterile 15 
tissue puncher and submerged in 100 uL of lysis/binding buffer from the Dynabeads 16 
mRNA Direct Micro Kit (ThermoFisher Scientific). The tissue was immediately 17 
homogenized in microcentrifuge tubes using a disposable pestle (Fisherbrand). 18 
mRNA was purified using the Dynabeads mRNA Direct Micro Kit (ThermoFisher 19 
Scientific) following the manufacturer’s recommended protocol for mRNA isolation 20 
from tissues. mRNA concentration was determined using the Qubit Fluorometer 2.0 21 
(ThermoFisher Scientific). 40 ng of mRNA from each sample was reverse 22 
transcribed using the SuperScript IV First-Strand Synthesis kit (Invitrogen) in an 23 
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Applied Biosystems GeneAmp PCR System 9700 (ThermoFisher Scientific). 1 
Real time qPCR and data analysis 2 
The cDNA was amplified in the ViiA7 Real-Time PCR machine (ThermoFisher 3 
Scientific) with a two-step PCR protocol (95°C for 10 minutes followed by 40 cycles 4 
of 95°C for 15 seconds and 60°C for 1 minute) using the Power SYBR Green PCR 5 
Master Mix (ThermoFisher Scientific) and KiCqStart SYBR Green Primers (Sigma-6 
Aldrich) (Table S1). Each reaction was performed in triplicate and dissociation 7 
curves were generated for all reactions to ensure primer specificity. All target genes 8 
were normalized to 3 reference genes (Sdha, Actb and Hprt) and the relative 9 
quantification using the comparative Ct method was determined using the 10 
DataAssist Software Version 3.01 (ThermoFisher Scientific). 11 
Statistical analyses 12 
Changes in E/IPSCs peak amplitude were measured from baseline and are 13 
shown as percentages as follows: (Peak amplitudepost−Peak amplitudebaseline/Peak 14 
amplitudebaseline)*100. Data are reported as means ± SEM and each data point 15 
represents the average of values in 1 min bins (6 evoked E/IPSCs) across recorded 16 
neurons.  17 
Two-way ANOVAs were used to compare multiple means of parametric data 18 
and Kruskal-Wallis H Test for non-parametric. A Bonferroni correction was used for 19 
multiple comparisons. Mann Whitney U test was used to compare specific means 20 
with an adjusted p-value according to the number of test performed. Fisher’s exact 21 
tests and Chi Squares analyzed contingency tables of the neuronal response 22 
distribution. All statistical analyses were done with SPSS Statistics Version 23 (SAS 23 
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Institute) or Prism 6. 1 
Results 2 
Post-synaptic activation of ovBNST neurons (0mV, 100msec, 2Hz, 5 mins) 3 
resulted in robust long-lasting depolarization-induced enhancement of inhibition (l-4 
DEI) in 59% of recorded neurons (time x group, F1,32=7.9, P<0.0001, n=20/34 cells l-5 
DEI from 21 rats; Figure 1A,F). The addition of the v-ATPase inhibitor concanamycin 6 
A (5µM) to the intracellular recording solution completely ablated ovBNST l-DEI 7 
that was thus vesicular release-dependent (Fisher’s Exact Test (NS-aCSF vs. NS-8 
Conc), P=0.04, n=0/4 cells l-DEI from 2 rats; Figure 1B,F). Additionally, rat strain 9 
and light cycle had no effect on l-DEI cell response (X2(2,n=34)=4.69, P=0.1; Table S2).  10 
The ovBNST is exclusively populated with GABA neurons that also contain 11 
the neuropeptides NT, CRF, dynorphin, or enkephalin (Day et al, 1999; Ju et al, 12 
1989b; Poulin et al, 2009). NT and CRF both increase ovBNST GABAA-inhibitory 13 
post-synaptic currents (IPSCs) through either NT receptors (NTR) or CRF receptors 14 
1 (CRFR1), respectively, and we hypothesized that one or both could be responsible 15 
for l-DEI (Kash et al, 2006; Krawczyk et al, 2013). As such we used a non-selective 16 
NTR antagonist (SR-142948, 10µM) and a CRFR1 selective antagonist (NBI-27914, 17 
1µM). Blocking NTR did not significantly block l-DEI (Fisher’s Exact Test (NS-aCSF 18 
vs. NS-SR), P=0.1, n=6/18 cells l-DEI from 11 rats; Figure 1C,F). Likewise, l-DEI was 19 
unaltered (56% of neurons) by the CRF antagonist (Fisher’s Exact Test (NS-aCSF vs. 20 
NS-NBI), P=1.0, n=5/9 cells l-DEI from 6 rats; Figure 1D,F). However, co-application 21 
of SR-142948 and NBI-27914 completely eliminated l-DEI indicating cooperation 22 
between NT and CRF in producing l-DEI, which is consistent with their co-23 
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localization in ovBNST neurons (Fisher’s Exact Test (NS-aCSF vs. NS-SR/NBI), 1 
P=0.004, n=0/8 cells l-DEI from 4 rats; Figure 1E,F)(Ju and Han, 1989a). 2 
Interestingly, bath application of NTR antagonist but not CRFR1 antagonist resulted 3 
in a reversible depression of GABAA-IPSCs suggesting constitutive NTR activity 4 
(Figure S2). Additionally, neither NT bath application or repetitive depolarization 5 
changed holding current or input resistance indicating membrane potential and 6 
channels were not changed by the neuropeptide (Table S3).  7 
We next determined whether l-DEI might be altered in the ovBNST of 8 
chronically stressed rats. CUS significantly facilitated l-DEI (Time, F1,10=5.0, P=0.009, 9 
n=11/11 cells l-DEI from 7 animals; Figure 2A) that was now measurable in all 10 
tested neurons compared to the NS group (X2(1,n=45)=6.6, P=0.01; Figure 2E). The 11 
NTR antagonist significantly reversed CUS-induced facilitation of l-DEI suggesting 12 
that NT took over modulation of ovBNST inhibitory synaptic transmission in 13 
stressed conditions (Fisher’s Exact Test (CUS-aCSF vs. CUS-SR), P=0.0002, n=2/10 14 
cells l-DEI from 4 rats, Figure 2B,E). In contrast, CRFR1 blockade had no effect on l-15 
DEI in CUS rats (Fisher’s Exact Test (CUS-aCSF vs. CUS-NBI), P=1.0, n=11/12 cells l-16 
DEI from 3 rats, Figure 2C,E) although both CRF and NT antagonists were necessary 17 
to completely eliminate l-DEI (Fisher’s Exact Test (CUS-aCSF vs. CUS-SR/NBI), 18 
P=0.0001, n=0/8 cells l-DEI from 5 rats, Figure 2D,E).  19 
We then investigated changes in mRNA expression of CRF, NT and their 20 
receptors in the dorsal BNST (dBNST) and, the central amygdala (CeA) that has 21 
strong inhibitory inputs onto the ovBNST and a similar neuropeptide array 22 
(expressing both CRF and NT) (Day et al, 1999). In support of CUS-induced changes 23 
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in the NT system, CUS significantly and selectively reduced dBNST Ntsr1 mRNA 1 
levels compared to NS (P=0.05, Figure 2F). In contrast, CUS had no significant effect 2 
on other stress-related transcripts in either the dBNST or the CeA (Figure 2F,G). 3 
In NS animals, post-synaptic depolarization resulted in long-lasting 4 
depolarization-induced reduction of excitatory synaptic transmission (l-DRE) in all 5 
tested neurons (time, F1,7=12.2, P<0.0001, n=9/9 cells l-DRE from 6 rats; Figure 6 
3A,C). The broad-spectrum opioid receptor antagonist naloxone (Nal, 10µM) 7 
abolished l-DRE suggesting that post-synaptic depolarization triggered the local 8 
release of endogenous opioids (Fisher’s Exact Test (NS-aCSF vs. NS-Nal), P=0.002, 9 
n=2/9 cells l-DRE from 4 rats, Figure 3B,C). The effect of post-synaptic activity on 10 
excitatory transmission was largely unaffected by CUS and still resulted in robust l-11 
DRE in the vast majority of recorded ovBNST neurons (time, F1,5=4.2, P=0.05, n=6/7 12 
cells l-DRE from 3 rats; Fisher’s Exact Test (NS vs. CUS), P=0.4, Figure 4A,C). Similar 13 
to NS conditions, Nal completely blocked l-DRE (Figure 4B), supporting the 14 
involvement of locally released endogenous opioids in this response (Fisher’s Exact 15 
Test (CUS-aCSF vs. CUS-Nal), P= 0.005, n=0/6 cells l-DRE from 3 rats, Figure 4C). 16 
CUS increases avoidance of open arms in the elevated plus maze (EPM) and 17 
immobilization in the forced swim test (FST) (Bessa et al, 2009). Converging 18 
evidence suggests that the BNST plays a key role in these chronic stress-induced 19 
anxiety- and depression-like phenomena (Daniel and Rainnie, 2016). Since CUS 20 
altered the neuromodulatory effect of NT in the ovBNST, we hypothesized that in 21 
vivo pharmacological blockade of ovBNST NTR might reverse CUS-induced 22 
avoidance of open arms in the EPM and immobility in the FST. As expected, CUS 23 
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significantly reduced the percentage of time spent in the open arms in saline-treated 1 
rats (U=5, p=0.0002, Figure 5D). Intra-ovBNST SR-142948 (5-10µM/side) had no 2 
effect on EPM behaviours in NS but significantly increased the percentage of time 3 
spent in the open arms in CUS (Kruskal-Wallis H test, X25=18.2, P=0.003, Figure 5D). 4 
SR-142948 (5-10µM/side) dose-dependently reversed this effect in CUS rats (U=7, 5 
P=0.0001, Figure 5D). SR-142948 had no effect on the number of open arms entries 6 
(Kruskal-Wallis H test, X25=5.3, P=0.4, Figure 5E) and did not affect total distance 7 
travelled in the open field (F(3,32)=0.7, p=0.6, Figure S3) therefore did not affect 8 
locomotion. In our conditions, intra-ovBNST NTRs blockade had no effect on 9 
immobility scores in the FST in either NS or CUS conditions (Kruskal-Wallis H test, 10 
X25=8.6, P=0.1, Figure 5F). 11 
Discussion 12 
We used brain slice whole-cell voltage-clamp recordings and discovered that 13 
in the ovBNST of NS rats, post-synaptic activation resulted in long-lasting 14 
depolarization-induced enhancement of inhibitory GABAA- and reduction of 15 
excitatory AMPA synaptic transmission that we termed l-DEI and l-DRE, 16 
respectively. NT and CRF both produced l-DEI while opioids were fully responsible 17 
for l-DRE. CUS facilitated l-DEI through an enhanced contribution of NT whereas l-18 
DRE was not affected. Pharmacological blockade of ovBNST NT receptors abolished 19 
CUS-induced reduction in open arm avoidance in the elevated plus maze, suggesting 20 
that NT may contribute to anxiety disorders (Laszlo et al, 2010; Saiz Ruiz et al, 21 
1992). 22 
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 In NS rats, post-synaptic activation produced l-DEI in slightly over half (59%) 1 
of recorded ovBNST neurons. There is clear evidence of various ovBNST neurons 2 
subpopulations with distinct morphological, neurochemical, or electrophysiological 3 
signatures that could explain this dichotomy (Day et al, 1999; Hammack et al, 2007; 4 
Ju et al, 1989b; Larriva-Sahd, 2006; Poulin et al, 2009). The neuron-specific 5 
expression of l-DEI may be tightly linked with specific neuropeptidergic profiles 6 
(Iremonger et al, 2009; Ludwig and Pittman, 2003). NT and CRF are highly 7 
concentrated in ovBNST neurons and both neuropeptides robustly potentiate 8 
GABAA-mediated synaptic transmission although through distinct pre- and post-9 
synaptic loci, respectively (Day et al, 1999; Ju et al, 1989a; Kash et al, 2006; 10 
Krawczyk et al, 2013). A study combining brain slice electrophysiology and single-11 
cell PCR showed that 60% of ovBNST neurons contain CRF which is precisely the 12 
percentage of l-DEI response we obtained, supporting a role for CRF in l-DEI 13 
(Dabrowska et al, 2011). Importantly, CRF and NT co-localize in the ovBNST and 14 
pharmacological blockade of both CRFR1 and NTR was necessary to completely 15 
abolish l-DEI (Ju et al, 1989a).  Application of either neuropeptide antagonist alone 16 
did not block l-DEI suggesting a cooperative mechanism where one neuropeptide 17 
activity can compensate for the blockage of the other. The exact functional link 18 
however remains elusive.  19 
Post-synaptic activation also resulted in opioid-dependent l-DRE in all 20 
recorded ovBNST neurons in NS rats, mitigating the possibility of sub-population 21 
effects. Only 41% of ovBNST neurons seem to express detectable amounts of 22 
enkephalins mRNA which poorly co-localizes with CRF or NT (Day et al, 1999). 23 
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Dynorphin is also abundant in the rat ovBNST and may have contributed to the 1 
opioid-dependent l-DRE we measured (Poulin et al, 2009). Enkephalin and 2 
dynorphin are potent inhibitors of excitatory synaptic transmission in the brain, 3 
supporting opioid-dependent l-DRE (Crowley et al, 2016). Opioid neuropeptides 4 
also modulate inhibitory transmission but we did not detect this response likely due 5 
to their short-lasting effects that we did not include in our analyses (Crowley et al, 6 
2016; Dumont and Williams, 2004). 7 
Altogether, our data show that blocking CRFR1, NTR, and opioid receptors 8 
completely abolished post-synaptic activation-induced modulation of synaptic 9 
transmission in the rat ovBNST. This does not preclude that other stimulation 10 
patterns may trigger local synthesis and/or release of other neuromodulators 11 
(Puente et al, 2010) or of other neuropeptides expressed in ovBNST neurons 12 
(Woodhams et al, 1983). In addition, we focused on long-lasting changes in synaptic 13 
transmission but short-duration phenomena have also been reported (Puente et al, 14 
2010). Unquestionably, numerous other neuropeptides, monoamines, or other 15 
molecules originating outside the ovBNST also robustly modulate synaptic 16 
transmission in this area (Dumont et al, 2004; Kash et al, 2006; Krawczyk et al, 17 
2013; Krawczyk et al, 2011b; Li et al, 2012; McElligott and Winder, 2008; Shields et 18 
al, 2009). Nevertheless, the objective of the study was to determine whether local 19 
neuropeptidergic synaptic modulation was affected by chronic stress. 20 
The neurophysiological mechanisms responsible for chronic stress-induced 21 
increase in anxiety-like behaviours are still largely unknown. Here, CUS facilitated l-22 
DEI and NT was responsible for this effect whereas the contribution of CRF was 23 
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mitigated by stress. This is a novel observation considering that NT has been largely 1 
overlooked as a potential contributor in the pathological consequences of stress, 2 
compared to CRF (Saiz Ruiz et al, 1992). Alteration of NT function could be due to an 3 
increase in NT synthesis, release or receptor membrane expression, binding or 4 
coupling. Under normal physiological conditions, NT increases inhibitory 5 
transmission by binding pre-synaptically to NTRs in the ovBNST (Krawczyk et al, 6 
2013). NT increases excitability and firing rate in other brains areas but we did not 7 
detect post-synaptic changes in the membrane potential or membrane channels 8 
opening suggesting these were not altered in the ovBNST (Jassar et al, 1999; Xiao et 9 
al, 2014)). Interestingly, the NTR receptor antagonist reversibly depressed GABAA-10 
IPSCs amplitude, in a seemingly inverse agonist way. The NTR2 exhibits constitutive 11 
activity on inositol phosphate production (Richard et al, 2001). Thus, the inverse 12 
agonist activity could occur through NTR2s that are also highly expressed in the 13 
BNST GABA neurons (Mazzone et al, 2016). However, it is still unknown whether 14 
the l-DEI is specific to or a combination of NTR1 and NTR2 activity and whether this 15 
is altered with CUS.  16 
When we investigated mRNA expression, only Ntsr1 mRNA, and not Nts or 17 
Ntsr2, was decreased in CUS rats compared to NS. Our findings corroborate other 18 
studies showing reduction of Ntsr1 mRNA following maternal separation or CRF-19 
overexpressing mice (Peeters et al, 2004; Toda et al, 2014). CUS decreasing Ntsr1 20 
mRNA expression may not result in a reduction of the NTR1 receptor expression at 21 
the cellular membrane. A decrease in Ntsr1 mRNA could be due to an increase in 22 
mRNA stability or a compensatory mechanism to reduce increased NT activity. The 23 
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latter explanation could indicate that NTR1 expression is actually increased with 1 
CUS and may be responsible for the changes in cell responses. Future studies 2 
investigating protein level expression is necessary to fully understand the 3 
neurophysiological changes occurring with CUS.  4 
The CUS paradigm in this study utilizes variable and uncontrollable stress 5 
where the animal does not habituate to the repeated stressors over time (Herman, 6 
2013). As predicted from previous studies, we found that rats that underwent the 7 
CUS paradigm spent significantly less time in the open arms compared to their NS 8 
counterparts. Whether this behaviour is “adaptive” or “maladaptive” is unclear. In 9 
the context of our EPM test, chronically stressed animals could be mounting an 10 
adaptive response to a reasonably imminent threat. Alternatively, their response 11 
could be interpreted as maladaptive as the animal limits their exploration and 12 
possibility of finding resources in the absence of an immediate threat. Since the rats 13 
had no controllability over the stressors, it is impossible to distinguish whether they 14 
were mounting a contextually appropriate or inappropriate response. 15 
Intra-ovBNST micro-injections of a NTR antagonist did however robustly 16 
modify CUS rats behaviours in the EPM, tying the sensitized NT neurophysiological 17 
response in ovBNST neurons of stressed rats with their anxiety profile. NTR 18 
blockade reversed the anxiogenic effect of CUS without affecting normal EPM 19 
exploratory behaviour displayed by NS rats. This is consistent with the fact that NT 20 
seems particularly important in mounting physiological and behavioural responses 21 
to face potentially extreme conditions (e.g. store fat, seek rich and highly rewarding 22 
nutrients, increase vigilance)(Deutch et al, 1987; Geisler et al, 2006; Krawczyk et al, 23 
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2013; Li et al, 2016; Luttinger et al, 1982). We also tested the effect of CUS on 1 
immobility in the FST but we did not find any changes in behaviour previously 2 
reported (Bessa et al, 2009). This discrepancy may be due to the shorter duration of 3 
the stress paradigm although our data showed that NT in the ovBNST may not 4 
contribute to this behaviour, regardless of the stress condition (Crestani et al, 2010).  5 
Overall, these findings elucidate a clear role for NT in chronic stress although 6 
we cannot conclude exactly how NT-induced increase of GABA transmission in the 7 
ovBNST translates into anxiety-like behaviour in the EPM. However, anatomical 8 
studies enable us to speculate how a NT-induced decrease of ovBNST activity could 9 
affect the HPA axis. The ovBNST has strong GABAergic outputs onto the fusiform 10 
nucleus of the BNST (fuBNST) that has direct inhibitory inputs onto the 11 
paraventricular nucleus of the hypothalamus (Dong et al, 2001). Lesion of the 12 
fuBNST attenuates HPA axis response suggesting it enhances PVN activity (Choi et 13 
al, 2007).  As such, a NT-mediated reduction of ovBNST inhibition output to the 14 
fuBNST could promote HPA axis excitation and result in a decrease of EPM open 15 
arm exploration. Parallel to this, in the PVN, blocking NT receptor during stress 16 
counteracts the increase of plasma corticosterone levels (Geisler et al, 2006). 17 
Additionally, decrease activity in ovBNST inhibitory projections could increase 18 
fear/anxiety (CeA), vigilance and arousal (substantia innominata), respiration 19 
(parabrachial nucleus) and, defensive response (periaqueductal gray) (Dong et al, 20 
2001). At this point however, we cannot discern the exact output of the ovBNST and 21 
whether it is affecting local or extrinsic circuitry.  22 
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The NT system in different brain areas could be working in concert to 1 
stimulate the HPA axis during stress conditions. Future studies should explore 2 
whether the magnitude of NT-activation of the HPA axis could possibly correlate 3 
with maladaptive vs adaptive behaviour. 4 
©    2017 Macmillan Publishers Limited. All rights reserved.
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Figure Legends 
Figure 1. Effect of post-synaptic depolarization on GABAA synaptic 
transmission in the ovBNST of non-stressed (NS) rats. Effect of post-synaptic 
activation on the amplitude of electrically-evoked GABAA-IPSCs over time in the 
ovBNST of NS rats in (A) aCSF (B) with intracellular concanamycin (5μM) (C) with 
extracellular SR-142948 (10μM) (D) with extracellular NBI-27914 (E) with 
extracellular NBI-27914 (1μM) and SR-142948 (10μM). Insets in panels A-E show 
representative ovBNST GABAA-IPSCs before and after post-synaptic activation 
followed by the proportion of responding neurons. Bar scale: 250 pA and 25 ms. 
Double arrows represent post-synaptic depolarization (0mV, 100ms at 2Hz, 5 mins) 
(F) Histogram summarizing the proportion of responding neurons to post-synaptic 
depolarization across different pharmacological treatments. Asterisk; p<0.05.  
 
Figure 2. Effect of post-synaptic depolarization on GABAA synaptic 
transmission in the ovBNST of chronic unpredictable stress (CUS) exposed 
rats. Effect of post-synaptic activation on the amplitude of electrically-evoked 
GABAA-IPSCs over time in the ovBNST of CUS rats in (A) aCSF, (B) with extracellular 
SR-142948 (10μM), (C) with extracellular NBI-27914 (1μM), (D) with extracellular 
NBI-27914 (1μM) and SR-142948 (10μM). Insets in panels A-D show representative 
ovBNST evoked GABAA-IPSCs before and after post-synaptic activation followed by 
the proportion of responding neurons. Bar scale: 250 pA and 25 ms. Double arrows 
represent post-synaptic depolarization (0mV, 100ms at 2Hz, 5 mins) (E) Histogram 
summarizing the proportion of responding neurons to post-synaptic depolarization 
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across different pharmacological treatments. (F, G) Histogram showing fold change 
in mRNA expression of Crhr1, Crhr2, Crh, Ntsr1, Ntsr2 and Nts in CUS compared to 
NS rats in the dBNST and CeA. Asterisks, p<0.05. 
 
Figure 3. Effect of post-synaptic depolarization on AMPA synaptic 
transmission in the ovBNST of NS rats. Effect of post-synaptic activation on the 
amplitude of electrically-evoked AMPA-EPSCs over time in the ovBNST of NS rats in 
(A) aCSF and (B) with extracellular Naloxone (1 µM). Insets in panels in A and B 
show representative ovBNST evoked AMPA-EPSCs before and after post-synaptic 
activation followed by the proportion of responding neurons. Bar scale: 250 pA and 
25 ms. Double arrows represent post-synaptic depolarization (0mV, 100ms at 2Hz, 
5 mins) (C) Histogram summarizing the proportion of responding neurons to post-
synaptic depolarization across different pharmacological treatments. Asterisk; 
p<0.05. 
 
Figure 4. Effect of post-synaptic depolarization on AMPA synaptic 
transmission in the ovBNST of CUS rats. Effect of post-synaptic activation on the 
amplitude of electrically-evoked AMPA-EPSCs over time in the ovBNST of CUS rats 
in (A) aCSF and (B) with extracellular Naloxone (1μM). Insets in panels A and B 
show representative ovBNST evoked AMPA-EPSCs before and after post-synaptic 
activation followed by the proportion of responding neurons. Bar scale: 250 pA and 
25 ms. Double arrows represent post-synaptic depolarization (0mV, 100ms at 2Hz, 
5 mins) (C) Histogram summarizing the proportion of responding neurons to post-
©    2017 Macmillan Publishers Limited. All rights reserved.
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synaptic depolarization across different pharmacological treatments. Asterisk, 
p<0.05. 
 
Figure 5. Effect of intra-ovBNST NTR pharmacological blockade on elevated 
plus maze (EPM) and forced swim test (FST) behaviours in NS and CUS rats. 
(A) Experimental timeline. (B) Photomicrograph showing a representative accurate 
bilateral cannula placement. (C) Drawing showing all intracranial cannula 
placements. (D) Bar graph representing the percentage of time spent in the EPM 
open arms (OA) across experimental groups. (E) Bar graph representing the 
number of OA entry across experimental groups. (F) Bar graph representing 
immobility scores in the FST across experimental groups. Sal, saline; SR5, SR 
142948 (5 μM); SR 10, SR-142948 (10 μM), Accl./Surg., acclimatation/surgeries;  
Hist, histology. Asterisks, p<0.05.   
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